Related Experiment Videos
Therapeutic modalities in portal hypertension
C J Rees1, M Hudson, C O Record
1Liver Unit, Freeman Hospital, UK.
European Journal of Gastroenterology & Hepatology
|January 1, 1997
Summary
Optimal management for acute variceal bleeding involves octreotide or terlipressin. Prevention of rebleeding is achieved with beta-blockers and nitrates, while TIPS and transplantation address severe cases.
Area of Science:
- Gastroenterology and Hepatology
- Interventional Endoscopy
- Transplant Surgery
Background:
- Variceal bleeding, a serious complication of portal hypertension, necessitates timely and effective management strategies.
- Current therapeutic approaches aim to control acute hemorrhage and prevent recurrent bleeding episodes.
Discussion:
- Pharmacological interventions like octreotide and terlipressin are first-line for acute variceal bleeding.
- Endoscopic therapies, including injection sclerotherapy and variceal banding, are crucial for hemostasis and obliteration of large varices.
- Transjugular intrahepatic portosystemic shunts (TIPS) offer a valuable option for refractory or uncontrolled bleeding and ascites.
Key Insights:
- Combined beta-blocker and nitrate therapy provides effective prophylaxis against rebleeding.
- Variceal banding is the preferred endoscopic method for large varices.
- TIPS and hepatic transplantation represent advanced treatment modalities for complex and severe cases.
Outlook:
- Continued research into optimizing medical and endoscopic therapies for variceal bleeding.
- Further evaluation of TIPS efficacy and long-term outcomes in managing portal hypertension complications.
- Refining criteria for hepatic transplantation in patients with advanced liver disease and portal hypertension.